All Topics
All Topics
Technology
Technology
AI
AI
Business
Business
Entertainment
Entertainment
News
News
Programming
Programming
Security
Security
Science
Science
Design
Design
Environment
Environment
Finance
Finance
Crypto
Crypto
Politics
Politics
Sports
Sports
Education
Education
Gaming
Gaming
Art
Art
Music
Music
Health
Health
Books
Books
Food
Food
Travel
Travel
Personal
Personal
Bluesky
Twitter

CGRP monoclonal antibody fremanezumab may reduce weather-triggered migraine attacks, study finds

By

Tara Haelle

7h ago· 6 min readenNews

Summary

A post hoc analysis of pooled data from two clinical trials found that the CGRP monoclonal antibody fremanezumab reduces the risk of weather-related migraine attacks in patients with episodic migraine. This is reportedly the first study to show that any preventive drug can help with weather-associated headaches, offering hope that preventive treatment may blunt the impact of weather-related migraine triggers.

Source

Twitter / XCGRP monoclonal antibody fremanezumab may reduce weather-triggered migraine attacks, study findsmdsc.pe

Key quotes

· 2 pulled
This is actually the very first study to show that any preventive drug can help weather-associated headache.
Preventive treatment may blunt the impact of weather-related migraine triggers, in what investigators say is a first for migraine prevention.
Snippet from the RSS feed
Preventive treatment may blunt the impact of weather-related migraine triggers, in what investigators say is a first for migraine prevention.

You might also wanna read

Comments

Sign in to join the conversation.

No comments yet. Be the first.